4//SEC Filing
Sorensen Mel 4
Accession 0000905148-25-001448
CIK 0001563577other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 4:17 PM ET
Size
5.1 KB
Accession
0000905148-25-001448
Insider Transaction Report
Form 4
Sorensen Mel
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2025-05-01+6,000,000→ 6,000,000 totalExercise: $0.02Exp: 2035-04-30→ Common Stock (6,000,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on June 1, 2025.
Documents
Issuer
Galera Therapeutics, Inc.
CIK 0001563577
Entity typeother
Related Parties
1- filerCIK 0001444783
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 4:17 PM ET
- Size
- 5.1 KB